Search Results
Displaying 151 - 160 of 161
… that a significant number of patients with conditions like Parkinson’s disease (PD), dementia with Lewy bodies (DLB), … ALS treatment or prevention in people at risk. The AMP for Parkinson’s Disease (AMP PD) program also relaunched last …
… where the lead compound advanced into Phase 1b studies for Parkinson's Disease and Phase 2 for treatment resistant … new therapeutics to treat cancer (Camposar, Vectibix), Parkinson’s disease, hematological disorders (Nplate), HIV … of innovative first-class agents for Alzheimer’s disease, Parkinson’s disease, pain/migraine, and schizophrenia. Merck …
… Image Sleep is an important part of your daily routine—you spend about … webpage describes how your need for sleep is regulated and what happens in the brain during sleep. Anatomy of Sleep … medications, stress, sleep environment, age, and what you eat and drink. Perhaps the greatest influence is the …
… New Drug (IND) package, and in some cases, design of early clinical protocol and launch of a first in human clinical trial. Once an investigator has been selected for … therapy and gene therapy products for over 70 clinical trials. Dr. Burger has chaired the Global Regulatory Affairs …
Tuesday, January 18, 2022
Researchers at the National Institutes of Health (NIH) have discovered specific regions within the DNA of neurons that accumulate a certain type of damage (called single-strand breaks or SSBs). This accumulation of SSBs appears to be unique to neurons, and it challenges what is generally understood about the cause of DNA damage and its potential implications in neurodegenerative diseases. In this study, damage within neurons was…
… variant of leucine-rich repeat kinase 2 associated with Parkinson’s disease is a partial loss-of-function mutation. …
… computed tomography scan (DaTscan) can help diagnose Parkinson’s disease. Image Lisa's Story Lisa, age 30, had …
… new therapeutics to treat cancer (Camposar, Vectibix), Parkinson’s disease, hematological disorders (Nplate), HIV …
… NINDS and other intramural investigators in both basic and clinical research programs requiring the use of …
… New York: Oxford University Press, pp. 314-315, 332. 59. Parkinson BR, Raymer A, Chang YL, Fitzgerald DB, Crosson B. … K. S., Singletary, F., Cato, M. A., Wierenga, C. E., Parkinson, R. B., Sherod, M. E., Bacon Moore, A., Ciampitti, …